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The amyloid beta-precursor protein (APP) and the Notch receptor are both type 1 integral transmembrane proteins, and both are cleaved by
presenilin-dependent gamma-secretase activity. In this study, we have demonstrated that the Notch intracellular domain (Notch1-IC) suppresses
APP-intracellular domain (AICD)-mediated ROS generation and cell death after being processed by gamma secretase. Notch1-IC physically
interacts with AICD, Fe65, and Tip60, thereby disrupting the association of the AICD–Fe65–Tip60 trimeric transcription activator complex in
AICD signaling. AICD–Fe65–Tip60 mediated reactive oxygen species generation was found to be suppressed by Notch1-IC. Furthermore,
AICD–Fe65–Tip60 was shown to mediate cell death in human neuroblastoma cells, and the overexpression of Notch1-IC inhibited cell death
induced by AICD–Fe65–Tip60. Collectively, our findings indicate that Notch1-IC plays the role of a negative regulator in AICD signaling via the
disruption of the AICD–Fe65–Tip60 trimeric complex.
© 2007 Elsevier B.V. All rights reserved.1. Introduction
Members of the Notch transmembrane receptor family are
known to play pivotal roles in the determination of cell fate
[1,2]. Notch receptors are cleaved proteolytically in their
transmembrane domains, via the activity of gamma-secretase.
Notch proteolysis is initiated after ligand binding, with the Delta
or Jagged family [3]. Upon ligand binding, the Notch receptor is
cleaved by tumor necrosis factor-converting enzyme (S2
cleavage), and the subsequent cleavage by gamma-secretase
(S3 cleavage) affects the release of the Notch intracellular
domain (Notch-IC) [4–6]. Notch-IC subsequently translocates
to the nucleus, in which it interacts with CBF1, the suppressor
of Hairless, and the Lag1 (CSL) family of transcription factors,Abbreviations: Notch1-IC, Notch1 intracellular domain; ΔE1, Notch1
lacking the extracellular domain; APP, Amyloid beta-Precursor Protein; AICD,
APP intracellular domain; ROS, Reactive oxygen species
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differentiation, proliferation, cell survival, and death [7]. Recent
studies have indicated that Notch exerts anti-apoptotic functions
via several mechanisms, including an augmentation of Akt
activity via the p56lck-PI3K pathway and the blockage of the
JNK signaling pathway via the disruption of the scaffold
functions of JNK-interacting protein 1 (JIP1) [8,9].
Amyloid beta-precursor protein (APP) is a type 1 integral
transmembrane protein, which closely resembles a cell surface
receptor [10,11]. The transmembrane domain of APP is
proteolytically cleaved by the activity of secretase [12]. The
APP is cleaved by gamma-secretase, generating a C-terminal C83
fragment, which then functions as the substrate for subsequent
cleavage by gamma-secretase. The cleavage of C83 by gamma-
secretase produces p3, the pathway of which has been recognized
as a non-amyloidogenic pathway [13,14]. APP can also be cut by
beta- and gamma-secretase. This amyloidogenic pathway
involves cleavage by beta-secretase, which generates a C-terminal
C99 fragment, and the subsequent cleavage of C99 by gamma-
secretase yields 40–42 residues of amyloid beta peptide (Abeta40
or Abeta42), and 57–59 APP-intracellular protein residues [14].
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the S3 cleavage of Notch generating Notch intracellular domain
and thereby produce AICD (APP-intracellular domain), which
traffics to the nucleus and is involved in downstream signal
transduction pathway [15,16]. AICD has been shown to bind to
the Fe65 nuclear adaptor protein and the Tip60 histone
acetyltransferase, thereby forming a nuclear multiprotein com-
plex, and stimulating the transcription of its own precursor, KAI1/
CD82, GSK3-beta, neprilysin, and p53 [17–22]. AICD also
affects the downregulation of PAT1, a soluble cytoplasmic protein
related to the kinesin light chain, and which has been shown to
repress retonic-acid gene expression [23]. AICD also triggers
apoptosis in neuronal cells via Tip60, and induces cytotoxicity in
differentiated neuronal cells [22,24].
APP and the Notch receptor have been recognized as
competitive substrates for gamma-secretase activity [25,26].
The production of Abeta is reduced by the stimulation of the
Notch receptor induced by Delta treatment. Notch activity was
also reduced in cases in which APP was overexpressed. In
addition, C99 andΔEN1, both of which are direct substrates for
the gamma-secretase of APP and the Notch receptor, respec-
tively, were shown to reduce the formation of the gamma-
secretase products from alternative substrates. Another group
reported that APP and the Notch receptor do not compete for
gamma-secretase activity [27]. This finding was consistent with
the results of a study in which it was determined that the
processing of the Notch receptor and APP by gamma-secretase
occur in different subcellular locales [28]. The group headed by
D'Adamio suggested that AICD might exert a suppressive
effect on Notch transcriptional activity through Numb [29].
Furthermore, the findings of several other studies have indicated
a physical association between Notch and APP [30–32].
However, the functional role of Notch in APP signaling has
yet to be clearly delineated.
In this report, we have demonstrated that the Notch
intracellular domain (Notch1-IC) suppresses APP-intracellular
domain (AICD)-mediated ROS generation, and cell death, via
the disruption of the association of the AICD–Fe65–Tip60
trimeric complex. Collectively, our results suggest that Notch1-
IC may play the role of a negative regulator in AICD signaling,
in a gamma-secretase independent manner.
2. Materials and methods
2.1. Cell culture and transient transfection
HEK293 cells, NIH3T3 cells, and SH-SY5Y cells were cultured at 37 °C in
Dulbecco's modified Eagle's medium (DMEM-Gibco) supplemented with 10%
fetal bovine serum and 1% penicillin/streptomycin in a humidified incubator
with an atmosphere of 95% O2, and 5% CO2. For transfection, the cells were
grown in adequate dishes to 50–60% confluence, and were then transiently
transfected with expression vectors, using calcium phosphate or Lipofectamine-
plus (Gibco) reagent.
2.2. Reporter gene assay
HEK293 cells were transfected with 100 ng of the Gal4-luciferase reporter
plasmid, in either the absence or presence of combinations of expression vectors,
along with beta-galactosidase, in 12-well plates. After 48 h of transfection, thecells were lysed with chemiluminescent lysis buffer, and analyzed using a
Luminometer (Berthold) for the Luciferase assays [33]. The luciferase reporter
activity in each sample was normalized according to the beta-galactosidase
activity measured within the same sample.
2.3. Coimmunoprecipitation assay
The HEK293 cells were transfected using the indicated expression vectors,
then harvested 48 h after transfection. The cells were washed with ice-cold PBS,
then lysed with RIPA lysis buffer [34]. For the immunoprecipitation
experiments, the lysates were subjected to 1 h of immunoprecipitation with
specific antibodies at 4 °C, with rotation. After incubation, protein A-agarose
was added to the samples for 1 h at 4 °C, with rotation. The precipitates were
then washed with ice-cold PBS three times, and boiled with 20 μl of 5× protein
sample buffer. The precipitates were separated via SDS-PAGE, and visualized
by immunoblotting with specific antibodies.
2.4. In vitro binding assay
The recombinant GST–Notch1-IC protein was expressed in Escherichia
coli strain BL21, using the pGEX system as indicated [35]. The GST–Notch1-
IC protein was then purified using glutathione-Sepharose beads (Sigma), in
accordance with the manufacturer's instructions. Equal amounts of GST or
GST–Notch1-IC fusion proteins were incubated with the lysates of HEK293
cells, which had been transfected for 3 h with combinations of expression
vectors at 4 °C, with rotation. After incubation, the beads were washed three
times with ice-cold PBS, and boiled with 20 μl of 5× protein sample buffer. The
precipitates were separated via SDS-PAGE, and the pull-down proteins were
detected via immunoblotting with specific antibodies.
2.5. Preparation of cytosolic and nuclear fractions
HEK293 cells transfected with the indicated vector constructs were rinsed
with ice-cold PBS, and harvested via 5 min of centrifugation at 3,000 rpm and
4×g. The dispersed cells were then homogenized with buffer A (10 mMHEPES,
pH 7.9, 10 mM KCl, 0.5 mM EDTA, 1 mM DTT, and 0.5 mM PMSF). After
15 min on ice, 10% NP-40 was added and vortexed vigorously for 10 s. The
resultant supernatant was then used as a cytosolic fraction, via 1–2 min of
centrifugation at 13,000 rpm and 4×g. The pellet was then homogenized with
buffer B (20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM DTT, and
1 mM PMSF). After 10 min of vigorous vortexing, the homogenates were
centrifuged for 10 min at 13,000 rpm at 4×g. The resultant supernatants were
then used as nuclear fractions [36].
2.6. Knockdown of Fe65 and Tip60 in cells
The nucleotide sequences for siRNA targeting Fe65 were as follows: Fe65:
5′-GAGUGCUAGCCUCCUAUUUdTdT-3′ (upper strand) and 3′-dTdTCU-
CACGAUCGGAGGAUAAA-5′ (lower strand), and Silencer® Negative
Control (Ambion). The siRNA targeting Tip60 was used as described previously
[37]. siRNAwere transfected into SH-SY5Y cells using Oligofectamine reagent
(InVitrogen) according to the supplier's manual.
2.7. Determination of intracellular ROS
The fluorescent probe, 2′,7′-dichlorodihydrofluorescein diacetate (DCFHDA;
Molecular Probes, Eugene, OR), was used in conjunction with a fluorescence
microscope (Leica DMLB2) or a fluorometer (RF5301-PC, Shimadzu) in order to
monitor net intracellular ROS generation [38]. SH-SY5Y cells were first
transfected with the indicated vector constructs. After 72 h, the cells were rinsed
in PBS and loaded with 10 μM DCFHDA dye in PBS for 15 min at 37 °C. The
cells were then fixed for 20 min in 4% formaldehyde at 4 °C, and stained with
DAPI. The stained cells were then analyzed for intracellular ROS via fluorescence
microscopy (Leica DM LB2). Intracellular ROS generation was assessed via the
monitoring of fluorescence resultant from the oxidation of 2′,7′-dichlorodihydro-
fluorescein (DCFH) to dichlorofluoroscein (DCF). The samples were subjected to
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expressed as the means ± S.D. of three independent experiments.
2.8. Assessment of nuclear change and apoptosis
For the apoptosis assay, SH-SY5Y cells were plated on cover glasses in 6-
well plates and transfected with GFP, AICD, Fe65, and Tip60, in the absence or
presence of Notch1-IC. 72 h afterward, the cells were fixed for 20 min with 4%
formaldehyde at 4?, and stained with DAPI. GFP positive cells were then
analyzed for nuclear lobulation, condensation, and fragmentation, via
fluorescence microscopy (Leica DM LB2). The cells were counted under a
microscope in five random fields, each consisting of 100–200 cells. The number
of cells with condensed nuclei relative to the total number of cells per field was
calculated, and expressed as a percentage [35].
3. Results
3.1. Notch1 inhibits APP mediated transcriptional activity
Because APP and Notch1 are cleaved by gamma-secretase
activity, we first attempted to determine whether or not Notch
plays a role in the regulation of APP-mediated signaling.
HEK293 cells were transfected with APP-Gal4 and pG5E1B-
Luc, and either the active Notch1 mutant ΔEN1, or an empty
vector. As had been expected, APP-mediated transcription
activity increased in these samples (Fig. 1A).We determined that
ΔEN1 attenuated the ability of APP-Gal4 to stimulate
transcription, in a dose-dependent manner, but exerted no
influence on the basal levels of Gal4-Luc activity (Fig. 1A).
Consistent with previous reports, we initially assumed this
phenomenon was a result of substrate competition. However,
further study began to intimate that Notch1 might suppress APP
transcription ability without substrate competition. In order to
ascertain whether or not AICD-induced transcription activity
was modified byΔEN1, the HEK293 cells were transfected with
AICD-Gal4, pG5E1B-Luc, and eitherΔEN1 or an empty vector.
We observed thatΔEN1 attenuated AICD-mediated signaling in
a dose-dependent manner (Fig. 1B). Thus, we are able to suggest
that the Notch-mediated attenuation of APP transcription
activity was not likely to be attributable to gamma-secretase
substrate competition.
Next, we attempted to determine whether the overexpression
of Notch1-IC might affect AICD-mediated signaling. HEK293
cells were transfected with AICD-Gal4, pG5E1B-Luc, and
either Notch1-IC or an empty vector. After 48 h, the cells were
evaluated with regard to extent luciferase activity. As shown in
Fig. 1C, in the Notch1-IC-expressing cells, AICD-mediated
transcription activity diminished in a substantial degree, thereby
indicating that Notch1-IC might function as a suppressor in
AICD signaling. Several previous reports have indicated that
Fe65 is a fundamental component of the AICD transcription
complex, and thereby plays a role in the stimulation of AICD
signaling, as compared to AICD alone [17,39]. In order to
determine more precisely the role played by Notch1-IC in
AICD-Fe65 mediated signaling, HEK293 cells were cotrans-
fected with AICD-Gal4, Fe65, and pG5E1B-Luc, as well as
either Notch1-IC or an empty vector. The expected increase in
the ability of AICD-Gal4 to stimulate transcription was
observed when the cells were cotransfected with Fe65 (Fig.1D). These results indicated that Notch1-IC exerted a
diminutive effect on AICD-Fe65-mediated signaling (Fig.
1D). In addition, Tip60, which is also involved in the potent
upregulation of AICD signaling, affected the formation of a
trimeric complex bridged with Fe65 [17,39]. In order to address
the role of Notch1-IC in AICD–Fe65–Tip60 (AFT) complex-
mediated signaling, HEK293 cells were cotransfected with
AICD-Gal4, Fe65, Tip60, pG5E1B-Luc, and either Notch1-IC
or an empty vector. As had been expected, when the cells were
cotransfected with Tip60, AICD signaling evidenced a dramatic
increase, as compared to either AICD alone or Fe65 co-
expression (Fig. 1E). Interestingly, Notch1-IC also attenuates
AICD signaling, and this can be augmented by the activity of
Fe65 and Tip60 cofactors (Fig. 1E). These findings compel us to
conclude that Notch1-IC affects a significant reduction in
AICD–Fe65–Tip60 (AFT) complex-mediated signaling.
3.2. Notch1-IC exerts no effects on the subcellular localization
of AICD, Fe65 and Tip60
In order to identify the cellular compartment in which AICD
interacts with Fe65 and Tip60, we have attempted to determine
the subcellular location of the transfected Notch1-IC within the
NIH3T3 cells, via immunofluorescence staining. AICD, Fe65
or Tip60 immunoreactivity was principally localized in the
nuclei, in the absence of Notch1-IC co-expression (data not
shown). However, in cases in which the cells were cotransfected
with Notch1-IC, AICD, Fe65, or Tip60 subcellular localization
were not substantially altered, thereby suggesting that Notch1-
IC does not significantly regulate the AICD signaling pathway
via the disruption of the cellular distribution of the AICD
transcription complex (data not shown). This would appear to
suggest that Notch1-IC exerts no significant influence on the
cellular localization of the AICD transcription complex. The
nucleus may constitute the primary site of interaction between
AICD and the Fe65 or Tip60 complexes, but the status of
interaction between these two proteins in the presence of
Notch1-IC remains to be determined.
3.3. Notch1-IC prevents the formation of the
AICD–Fe65–Tip60 trimeric complex
In order to delineate more precisely the manner in which
Notch1-IC prevents AICD–Fe65–Tip60 complex-mediated
transcription, we conducted a series of co-immunoprecipitation
experiments. Previous reports have indicated that the cytoplas-
mic tail of APP forms a multimeric complex with the Fe65
nuclear adaptor protein and the Tip60 histone acetyltransferase
[17]. In order to determine the role of Notch1-IC in AICD-Fe65
association, the HEK293 cells were cotransfected with AICD-
GFP, Fe65-Myc, and either flag-Notch1-IC or an empty vector.
In our in vivo co-immunoprecipitation analyses of the physical
association between AICD and Fe65 , we obtained identical
results as the previous report with regard to the association
between AICD and Fe65 (Fig. 2A). We also determined that this
binding was suppressed via the co-expression of Notch1-IC,
thereby implying that the binding of AICD to Fe65 is abrogated
Fig. 1. Notch1 inhibits APP-mediated transcriptional activity. (A) HEK293 cells were transfected with Gal4-luciferase along with APP–Gal4 and Myc-ΔEN1, as
indicated. (B) HEK293 cells were transfected with Gal4-luciferase, along with AICD–Gal4 and Myc-ΔEN1 as indicated. (C) HEK293 cells were transfected with
Gal4-luciferase along with AICD–Gal4, and Myc–Notch1-IC as indicated. (D) HEK293 cells were transfected with Gal4-luciferase along with AICD–Gal4, Fe65 and
Myc–Notch1-IC as indicated. (E) HEK293 cells were transfected with Gal4-luciferase along with AICD–Gal4, Fe65, Tip60, and Myc–Notch1-IC as indicated. After
48 h of transfection, the cells were lysed and the luciferase activity was assayed. Data were normalized with beta-galactosidase. These results represent the
means±average deviation of triplicates from one of three independent experiments. (A–E) The cell lysates were also subjected to immunoblotting analysis with
the anti-Myc antibody. The data we evaluated for significant difference by Student's t-test compare to APP–Gal4 or AICD–Gal4 (*,p<0.001).
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however, it forms a complex with AICD through the Fe65
adaptor protein. In order to determine the molecular effects of
Notch1-IC on the binding between Fe65 and Tip60, we
conducted another set of similar experiments, thereby allowing
us to pin down the relevant mechanism more precisely.
HEK293 cells were cotransfected with Fe65-Myc, HA-Tip60,
and either Flag–Notch1-IC or an empty vector. Fe65 and Tip60
were observed to bind to each other within the cells; however,
this binding was also clearly suppressed by the co-expression of
Notch1-IC, which suggests that Notch1-IC plays a negative role
the association of Fe65 and Tip60, via some heretoforeunknown mechanism (Fig. 2B). At this point, we evaluated
the formation of the trimeric complex, with or without Notch1-
IC overexpression, in order to define more precisely the role of
Notch1-IC in the negative regulation of AICD–Fe65–Tip60-
mediated signaling. Remarkably, the formation of the AICD–
Fe65–Tip60 trimeric complex was prevented in the presence of
Notch1-IC; this implies that Notch1-IC may play a crucial role
with regard to the downregulation of AICD-mediated tran-
scription activity, via the disruption of the formation of the
trimeric active complex (Fig. 2C). To address the possible
association between GFP and Fe65, Tip60 or Notch1-IC, we
performed co-immunoprecipitation assay. We could not find
Fig. 2. Notch1-IC prevents AICD–Fe65–Tip60 trimeric complex formation. (A) HEK293 cells were transfected for 48 h with the indicated combinations of expression
vectors for AICD–GFP, Fe65–Myc, and Notch1-IC–Flag. The cell lysates were then subjected to immunoprecipitation with anti-GFP antibody, and the resulting
precipitates were subjected to immunoblotting analysis with anti-Myc antibodies. The cell lysates were also subjected to immunoblotting analysis with the indicated
antibodies. (B) The HEK293 cells were transfected for 48 h with the indicated combinations of expression vectors for Fe65–Myc, HA–Tip60, and Notch1-IC–Flag.
The cell lysates were then subjected to immunoprecipitation with anti-HA antibody, and the resultant precipitates were subjected to immunoblotting analysis with anti-
Myc antibodies. The cell lysates were also subjected to immunoblotting analysis with the indicated antibodies. (C) The HEK293 cells were transfected for 48 h with the
indicated combinations of expression vectors for AICD–GFP, Fe65–Myc, HA–Tip60, and Notch1-IC–Flag. The cell lysates were then subjected to
immunoprecipitation with anti-HA antibodies, and the resulting precipitates were subjected to immunoblotting analysis with anti-GFP and anti-Myc antibodies.
The cell lysates were also subjected to immunoblotting analyses with antibodies against GFP, Myc, HA and Flag. (D) The HEK293 cells were transfected for 48 h with
the indicated combinations of expression vectors for pEGFP, Fe65–Myc, HA–Tip60, and Myc–Notch1-IC. The cell lysates were then subjected to
immunoprecipitation with anti-GFP antibody, and the resulting precipitates were subjected to immunoblotting analysis with anti-HA or anti-Myc antibody. (E)
The HEK293 cells were transfected for 48 h with the expression vectors for AICD–GFP. The cell lysates were then subjected to GST-pull down experiments with
immobilized GSTor GST–Tip60. The HEK293 cells were transfected for 48 h with the indicated combinations of expression vectors for AICD–GFP and HA–Tip60.
The cell lysates were then subjected to immunoprecipitation with anti-HA antibody, and the resulting precipitates were subjected to immunoblotting analysis with anti-
GFP antibody. Asterisks indicate non-specific bands of cell lysates.
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suggesting that GFP does not interfere with our findings (Fig.
2D). Furthermore, according to the results of our pull-down
binding and co-immunoprecipitation experiments, we were
able to conclude that AICD does not interact directly with
Tip60 (Fig. 2E).3.4. Notch1-IC binds directly to AICD, Fe65, and Tip60
In order to characterize the physical interaction occurring
between Notch1-IC and the components of the AICD–Fe65–
Tip60 trimeric complex, we conducted a series of in vitro
binding assays. In these in vitro binding studies, we mixed the
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Notch1-IC fusion proteins, which had been immobilized on
glutathione-agarose beads (Fig. 3A). Immunoblotting analysis
using anti-GFP antibody indicated that AICD had bound
directly to GST–Notch1-IC, but not to the GST control (Fig.
3A). Sequential experiments were then conducted in an in vitro
binding study, in which GST and GST–Notch1-IC were applied
to cell lysates harboring Fe65 or Tip60 (Figs. 3B, C). According
to the results of our pull-down binding experiments, we were
able to conclude that Notch1-IC interacted directly with AICD,
Fe65, and Tip60.
We then attempted to evaluate the degree to which Notch1-
IC physically interacted with AICD, Fe65, or Tip60 in vivo, via
co-immunoprecipitation experiments, conducted as described
above. First, Flag–Notch1-IC and/or GFP-AICD were trans-
fected into HEK293 cells in order to detect physical binding.
After transfection, the cells were lysed and immunoprecipitated
against Notch1-IC, then subjected to immunoblotting against
AICD. AICD was detected in the Notch1-IC-immunoprecipi-Fig. 3. Notch1-IC binds directly to AICD, Fe65 and Tip60, respectively, in vitro.
Recombinant GST and GST–Notch1-IC proteins were immobilized onto GSH-
agarose, as described in the Materials and methods section. (A) The HEK293
cells were transfected for 48 h with the expression vectors for AICD–GFP. The
cell lysates were then subjected to GST-pull down experiments with
immobilized GST or GST–Notch1-IC. (B) The HEK293 cells were transfected
for 48 h with the expression vectors for Myc–Fe65. The cell lysates were then
subjected to GST-pull down experiments with immobilized GST or GST–
Notch1-IC. (C) The HEK293 cells were transfected for 48 h with the expression
vectors for Flag–Tip60. The cell lysates were then subjected to GST-pull down
assays with immobilized GST or GST–Notch1-IC. (A–C) Proteins bound to
GST or GST–Notch1-IC was analyzed via immunoblotting with anti-GFP, anti-
Myc or anti-Flag antibody. GSTor GST–Notch1-IC proteins were visualized via
staining with Coomassie's Brilliant Blue.
Fig. 4. Notch1-IC interacts directly with AICD, Fe65, and Tip60, respectively, in
intact cells. (A) HEK293 cells were transfected for 48 h with the indicated
combinations of AICD–GFP and Notch1-IC–Flag expression vectors. (B)
HEK293 cells were transfected for 48 h with the indicated combinations of
expression vectors for Fe65–Myc and Notch1-IC–Flag. (C) HEK293 cells were
transfected for 48 h with the indicated combinations of HA–Tip60 and Notch1-
IC–Flag expression vectors. The cell lysates were then subjected to
immunoprecipitation with anti-Flag antibody, and the resulting precipitates
were subjected to immunoblotting analysis with anti-GFP, anti-Myc, or anti-HA
antibody. The cell lysates were also subjected to immunoblot analysis with the
indicated antibodies. Asterisks indicate non-specific bands of cell lysates.tated complexes, thereby suggesting that Notch1-IC and AICD
might form a stable complex in vivo (Fig. 4A). Having
demonstrated the role of Notch1-IC in the functioning of Fe65,
we attempted to determine whether Fe65 is also sequestered by
Notch1-IC. In order to assess this hypothesis, Flag–Notch1-IC
and/or Myc-Fe65 were transfected into HEK293 cells, and
immunoprecipitated against Notch1-IC, then subjected to
immunoblotting against Fe65. We also assessed the physical
association between Notch1-IC and Fe65 (Fig. 4B). We also
conducted an evaluation of the possible association between
Tip60 and Notch1-IC. HEK293 cells were cotransfected with
HA-Tip60 and/or flag-Notch1-IC, and immunoprecipitated
against Notch1-IC, then subjected to immunoblotting against
Tip60. Interestingly, Tip60 also appears in Notch1-IC-immu-
noprecipitated complexes (Fig. 4C). Collectively, our results
suggest that Notch1-IC exerts a sequestering effect in the
AICD–Fe65–Tip60 complex, therefore facilitating the disso-
ciation of this trimeric complex into single molecules.
In order to determine the location in which Notch1-IC binds
to the AFT complex, we isolated the nuclear and cytoplasmic
fractions from cells expressing Notch1-IC and the AFTcomplex.
We then performed a co-immunoprecipitation of Notch1-IC and
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fractions. AICD, Fe65, and Tip60 bound to Notch1-IC
principally in the nucleus (Figs. 5A, C). However, a slight
degree of AICD and Fe65 also bound to Notch1-IC in the
cytoplasm (Fig. 5B). Furthermore, our immunoblot data imply
that this is caused by the fact that Notch1-IC is mainly present in
the nucleus and bears no relation to preferential binding sites of
AFT with Notch1-IC in the nucleus.Fig. 5. Notch1-IC physically interacts with AFT components in the nucleus. (A) H
expression vectors. (B) HEK293 cells were transfected for 48 h with Fe65–Myc and
with Flag–Tip60 and HA–Notch1-IC expression vectors. The cells were then fraction
nuclear fractions were immunoprecipitated with anti-HA antibody and the resulting pr
anti-Flag antibody. The cell lysates were also subjected to immunoblotting analy
fractionation, the cell lysates were subjected to immunoblotting analyses with anti-L3.5. Notch1-IC suppresses AICD-induced ROS generation
As the cytotoxicity of AICD overexpression is thought to
be associated with redox cycling and the generation of
reactive oxygen species (ROS), it appeared reasonable to
attempt to determine whether or not SH-SY5Y neuroblastoma
cells overexpressing the AICD–Fe65–Tip60 (AFT) complex
would accumulate an elevated amount of free radicals. InEK293 cells were transfected for 48 h with AICD–GFP and Notch1-IC–HA
HA–Notch1-IC expression vectors. (C) HEK293 cells were transfected for 48 h
ated into cytosolic (C), and nuclear (N) fractions. Equal amounts of cytosolic and
ecipitates were subjected to immunoblotting analysis with anti-GFP, anti-Myc or
sis with antibodies against GFP, HA, Myc and Flag. (A–C) To validate the
amin (nuclear marker) and anti-beta-actin (cytosolic marker) antibodies.
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intracellular oxidation of the DCFHDA reporter fluorescent
dye. ROS generation was found to have gradually increased,
in a time-dependent manner in the AFT-transfected cells (Fig.
6A). In order to address the importance of the role of Fe65 or
Tip60 in ROS generation, SH-SY5Y neuroblastoma cells were
transfected with the AFT complex, with or without siCon,
siFe65 or siTip60. Unlike control short interference plasmid
transfected cells, short interference Tip60 or Fe65 transfected
cells contained a low level of Tip60 or Fe65 (Fig. 6B). The
AFT-mediated elevation of ROS generation was down-
regulated by siFe65 and siTip60, but not by control siRNA,
thereby suggesting that Fe65 and Tip60 play a critical role in
AFT-mediated ROS generation (Fig. 6C). However, Fe65–
Tip60 (FT), Fe65 alone (F), or Tip60 alone (T) did not
increase of ROS generation (Fig. 6C). In addition, we alsoFig. 6. AICD–Fe65–Tip60 mediated ROS generation is suppressed by Notch1-IC. (
vectors for AICD, Fe65, and Tip60. Cellular ROS generation was evaluated in a time-
transfected with the expression vectors for HA–Tip60, Fe65–Myc, siCon, siTip60 and
with anti-HA, anti-Myc or anti-β-actin antibody. (C) SH-SY5Y human neuroblasto
siCon, siFe65 and siTip60 as indicated. (D) SH-SY5Y human neuroblastoma cells we
72 h, DCF fluorescence intensity was determined as described. SH-SY5Y cells wer
intensity as a positive control. The relative DCF fluorescence intensity (arbitrary) s
experiments. The data we evaluated for significant difference by Student's t-test com
T, Tip60).determined that AFT-mediated ROS generation decreased
gradually in a siTip60 dose-dependent manner (data not
shown). Control siRNA does not effect on AFT-mediated
ROS generation (Fig. 6C bar 1 and 2). At this point, we
attempted to ascertain whether Notch1-IC could suppress
AFT-mediated ROS generation in the SH-SY5Y cells.
Interestingly, we determined that total ROS generation
decreased drastically, in a dose-dependent manner, when the
cells were co-transfected with Notch1-IC (Fig. 6D).
3.6. Notch1-IC inhibits AICD–Fe65–Tip60 complex-induced
neuronal cell death
As had been expected, the overexpression of AICD, Fe65,
and Tip60 in SH-SY5Y human neuroblastoma cells facilitates
nuclear lobulation and fragmentation by DAPI staining, therebyA) SH-SY5Y human neuroblastoma cells were transfected with the expression
dependent manner, as indicated. (B) SH-SY5Y human neuroblastoma cells were
siFe65 as indicated. The cell lysates were subjected to immunoblotting analyses
ma cells were transfected with the expression vectors for AICD, Fe65, Tip60,
re transfected with AICD, Fe65, Tip60 and Notch1-IC expression vectors. After
e exposed to 10 mM H2O2 for 20 min and then determined DCF fluorescence
hown is representative of triplicate experiments from one of three independent
pare to AFT (*,p<0.001). (AFT, AICD–Fe65–Tip60; FT, Fe65–Tip60; F, Fe65;
Fig. 7. AICD–Fe65–Tip60 multimeric complex-induced neuronal apoptosis is
inhibited by Notch1-IC. (A) SH-SY5Y cells were transfected with AICD, Fe65,
Tip60, siCon, siFe65, or siTip60 expression vectors, along with GFP, as
indicated. After 72 h of transfection, the cells were fixed and stained with DAPI.
The GFP-positive cells were analyzed for apoptotic nuclei with a fluorescence
microscope. (B) SH-SY5Y human neuroblastoma cells transfected with AICD,
Fe65, and Tip60 in the absence or presence of Notch1-IC. After 72 h of
transfection, the cells were fixed and stained with DAPI. The GFP-positive cells
were analyzed for apoptotic nuclei via fluorescence microscopy. These results
represent the means±average deviation of triplicates from one of three
independent experiments. The data we evaluated for significant difference by
Student's t-test compare to AFT (*,p<0.001).
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investigation to determine whether the suppression of Fe65 or
Tip60 by siRNA might influence the levels of cell death
occurring in the SH-SY5Y cells. Levels of the cell death
triggered by the overexpression of the AFT complex were
diminished by the knock-down of Fe65 or Tip60 in cases in
which siRNA against Fe65 and Tip60, respectively, was
expressed (Fig. 7A). Moreover, we also found that Fe65–
Tip60 (FT), Fe65 alone (F), or Tip60 alone (T) did not induce
significant cell death (Fig. 7A). Control siRNA does not effect
on AFT-mediated ROS generation (Fig. 7A bar 1 and 2).
Notch1-IC is a well-established anti-apoptotic factor. In Figs. 5
and 6, it can be seen that Notch interferes with the formation of
the AICD–Fe65–Tip60 trimeric complex, as well as ROS
generation, via physical interaction. Therefore, we attempted to
determine whether Notch1-IC prevents AFT-induced cell death.
Interestingly, in the presence of Notch1-IC, the frequency with
which AFT-mediated cell death occurred had been markedly
reduced (Fig. 7B). Our results appear to suggest that Notch1-IC
prevents AICD–Fe65–Tip60-induced cell death via the disrup-
tion of the formation of the trimeric complex.
4. Discussion
In this study, we have determined that AICD-induced cell
death and ROS generation is regulated by Notch1-IC, via thedisruption of the formation of the AICD–Fe65–Tip60 trimeric
complex, suggesting that after cleavage by gamma-secretase
Notch and APP signaling can be interconnected in certain
condition.
Previous reports have suggested the possibility of cross-talk
between the Notch and APP signaling pathways, occurring via
gamma-secretase substrate competition [25,26]. However, other
reports suggest that negative cross-talk occurs between Notch and
APP signaling, in a gamma-secretase-independent manner [27]
and the processing of Notch and amyloid precursor protein by
gamma-secretase is spatially distinct [28]. That is, Notch1-IC-
mediated gene expression is negatively regulated by AICD, via
some heretofore-undelineated mechanism [28]. Furthermore,
AICD, the epsilon cleavage of APP, received particular attention
because it resembles the S3 Notch cleavage generating Notch-IC.
Translocation of AICD into nucleus forms a trimeric complex
with Fe65 and Tip60 and induces transcription of several genes
such as APP, KAI1/CD82, GSK3-beta, neprilysin, and p53 [17–
22]. This transcription activity of AICD appears to mediate
important physiological functions [15,16,22]. The functional
involvement of Notch1-IC in AICD signaling, then, remains a
matter of some inquisitiveness. Our results showed that AICD
transcriptional activity was inhibited by the presence of Notch1-
IC, which suggests that Notch1-IC may also involve the
suppression of AICD transcriptional activity. It has been shown,
in previous reports, that Fe65 and Tip60 are the key component in
the AICD transcription complex, and stimulate AICD signaling to
a greater degree than AICD alone [17]. We demonstrated that the
expression of Notch1-IC results in a down-regulation of AICD–
Fe65–Tip60 (AFT) complex-mediated transcriptional activity. At
this point, the manner in which Notch1-IC plays its negative role
in AFT complex-mediated transcriptional activity necessitates
further investigation.
A recent report suggests that Notch1-IC binds directly to
Fe65 in cases of Down's syndrome [32]. Furthermore, several
reports have previously suggested that Notch may interact
directly with APP in intact cells [30–32]. We have determined
that Notch1-IC interacts directly with AICD, Fe65, and Tip60,
thereby negatively regulating the formation of the AICD–Fe65–
Tip60 trimeric complex. In addition, we also determined that
AICD, Fe65 and Tip60 bind primarily to Notch1-IC in the
nucleus, but the AICD and Fe65 bind to Notch1-IC to a slight
degree in the cytoplasm, which suggests that Notch1-IC is also
able to regulate the dissociation of the AFT complex, via
physical association. However, the dissociation sequence and
precise relevant mechanisms in this phenomenon remain
obscure.
AICD has previously been suggested to exert a regulatory
effect on cellular Ca2+ homeostasis, which is closely related to
ROS generation in neuronal cells [40]. Also, chronic hypoxia
has been shown to alter Ca2+ homeostasis, thereby elevating
AICD generation and cellular ROS levels [41]. In a co-culture
of APP-wt neuroblastoma cells with microglia, microglial cells
generated ROS via an NADPH oxidase-dependent process, and
neuronal cells evidenced increased apoptosis [42]. No evidence
has yet been obtained to suggest that the AICD–Fe65–Tip60
complex plays a regulatory role with regard to ROS generation.
745S.-Y. Kim et al. / Biochimica et Biophysica Acta 1773 (2007) 736–746Nevertheless, ROS may play a critical role in neuronal cell
death [43]. In this study, we have demonstrated that the
overexpression of the AICD–Fe65–Tip60 complex increases
levels of ROS and that treatment with the siRNAs for Fe65 or
Tip60 reverses this effect. These ROS levels are suppressed by
co-expression with Notch1-IC, in a dose-dependent manner.
Therefore, we conclude that AFT complex-mediated gene
expression is linked to ROS generation, and that Notch1-IC
suppresses the generation of ROS via the sequestration of AFT
components.
In AICD-induced cell death, Fe65 and Tip60 play a critical
role via the up-regulation of some apoptosis-related proteins
and p53 [22,24]. We have observed AFT complex-mediated cell
death in neuroblastoma cells. AFT-induced cell death was
suppressed by the co-expression of siRNA for Fe65 or Tip60.
We also determined that Notch1-IC inhibits AICD–Fe65–
Tip60-induced cell death in neuroblastoma cells.
Our results have demonstrated that Notch1-IC represses
AICD–Fe65–Tip60 complex-mediated gene expression and
cell death. Henceforth, the results of this study may begin to
shed light on what may be a signal cross-talk mechanism of
Notch and APP, or may be pointing to the existence of gamma-
secretase independent cross-talk.
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